Summary: The actions of Bosentan and PD155080, non peptide endothelin receptor antagonists, were examined in feline pial arterioles in situ following middle cerebral artery (MCA) occlusion to gain insight into the cerebro vascular influence of endogenous endothelins in focal ce rebral ischaemia. Immediately following permanent MCA occlusion, all pial arterioles overlying the suprasylvian and ectosylvian gyri displayed marked dilatations, which were maintained in a population of vessels but differen tiated into sustained constrictions in others. Perivascular constricted arterioles overlying the ectosylvian and su prasylvian gyri also elicited an increase in the calibre of arterioles (68 ± 60% from preinjection baseline; n = 13).
The survival of cerebral tissue is dependent on the continuous delivery of substrates by the blood. Multiple homeostatic mechanisms exist to protect blood flow to the brain from compromise (Paulson et aI. , 1990) . Despite these physiologic mecha nisms, constrictor mechanisms that limit tissue per-In contrast, the microapplication of CSF (pH 7.2) elicited small reductions in pial arteriolar calibre of postocclusion constricted arterioles ( -8 ± 13% from preinjection base line; n = 8). The peri vascular micro application of PD155080 (30 J..L M) around postocclusion dilated pial ar terioles overlying the ectosylvian and suprasylvian gyri elicited an increase in the calibre of arterioles (11 ± 10% from preinjection baseline; n = 38). The perivascular mi croapplication of Bosentan (30 J..L M) around postocclusion dilated arterioles elicited an increase in the calibre of ar terioles (16 ± 15% from preinjection baseline; n = 36). In contrast, the microapplication of CSF (pH 7.2) elicited small reductions in pial arteriolar calibre of postocclusion dilated arterioles ( -9 ± 6% from preinjection baseline; n = 44). Peri"ascular microapplication of Bosentan or PD155080 had minimal effect on the calibre of pial arte rioles on the parasagittal gyrus (anterior cerebral artery territory), although these arterioles had also displayed sustained dilatation following MCA occiusio "'�' These re sults indicate that contractile factors (whose effects can be reversed with endothelin receptor antagonists) con strict or impair dilatation of cortical resistance arterioles in an acute cerebral ischaemic episode. Key Words: Focal cerebral ischaemia-Bosentan-Endothelin receptor an tagonist-Endothelin-Cerebral arterioles-Cerebral ischaemia.
fusion to the ischaemic and periischaemic regions are well-recognized in cerebral ischaemia. Although a variety of mechanisms have been proposed to ac count for sub maximal dilatation in the penumbra of a focal ischaemic episode, such as vasoconstriction, increased tissue pressure, and luminal obstruction, the precise cause of impairment of blood flow to the ischaemic penumbra is unknown (Teasdale et al., 1981; Hatashita and Hoff, 1986; Wahl and Schilling, 1993) .
The endothelin family of peptides, endothelin-l (ET-l), endothelin-2 (ET-2), and endothelin-3 (ET-3), are profound vasoconstrictors of cerebrovascu-lar smooth muscle in vitro and in vivo (Robinson and McCulloch, 1990; Adner et aI., 1993; Salom et aI., 1993; Feger et aI., 1994) . Circumstantial evi dence has implicated endogenous endothelins in a variety of cerebrovascular pathologies (Suzuki et aI., 1992; Ziv et aI., 1992) . Exogenous endothelin-l can overwhelm homeostatic mechanisms in the nor mal CNS and reduce CBF to pathologically low lev els (Robinson et aI., 1990; Fuxe et aI., 1992; Macrae et aI., 1993; Sharkey et aI., 1993) . ET-l also exac erbate focal ischaemic damage (Nikolov et aI. , 1993) . Elevations of endothelin immunoreactivity in brain tissue have been described following perma nent focal ischaemia in the rat, and endothelin lev els are increased in the CSF following ischaemic stroke (Duverger et aI., 1992; Ziv et aI. , 1992; Gang Zhi et aI., 1993; Barone et aI., 1994) .
The effects of the endothelins are mediated via two receptor subtypes, endothelin-A (ETA) and en dothelin-B (ETB) (Masaki et aI., 1994) . The predom inant effect of ETA receptors is to mediate vasocon striction, while ET B receptors mediate vasodilata tion. However, vasoconstrictor effects mediated by ET B receptors have been reported in some vascular beds (Masaki et aI., 1994) . Bosentan is an antago nist of both ETA and ET B receptor subtypes, whereas PD155080 is a selective antagonist for the ETA receptor subtype (Clozel et aI., 1994; Doherty et aI., 1995) . In feline cortical pial arterioles in situ, perivascular coadministration of ET -1 with either Bosentan or PD155080 prevents the vasoconstrictor effect of ET -1 with half maximal inhibition at a con centration of 1 J..L M of each antagonist (Patel et aI., 1994 (Patel et aI., , 1995b . Under normal physiologic conditions, Bosentan per se (in concentrations up to 300 J..L M) and PD155080 per se (in concentrations up to 30 J..L M) have no demonstrable effect on pial arteriolar diameter (Patel et aI., 1994 (Patel et aI., , 1995b . In the study reported here, we employed perivascular microap plication of Bosentan and PD155080 around feline pial arterioles to gain insight into the pathophysio logic role of endogenous endothelins in vasomotor disturbances associated with acute cerebral isch aemia.
MATERIALS AND METHODS

Surgical preparation
The studies were carried out using 10 adult female cats, weighing between 2 and 3 kg. Anaesthesia was induced using alphaxolone/alphadolone (Saffau, Glaxo) admin istered into the radial vein. The animals were then intu bated, and positive pressure ventilation with N20/02 (70/ 30%) was initiated. The femoral arteries and veins were cannulated for the monitoring of arterial blood pressure and arterial blood gas status and also for administration of J Cereb Blood Flow Me/ab, Vol. 16, No.4, 1996 fluids and drugs. Anaesthesia was maintained using a-chloralose (60 mg/kg), and supplements of 1-2 ml (1% solution) were administered i.v. during the experiment. The inspired gas mixture was altered to oxygen supplemented air (25% 02) prior to the start of the mi croapplication studies.
The animals were placed in a stereotactic frame. After a midline incision, the scalp was retracted and sutured onto a metal ring to form a well over the calvarium. The temporalis muscle was retracted, and a rectangular craniectomy (3 x 2 em) was made over the parietal cor tex, using a saline-cooled dental drill, exposing the parasagittal, suprasylvian, and ectosylvian gyri. The ex posed dura was bathed with mineral oil at 38°C to form a pool, and a continuous flow of oil at a rate of -1 ml/min was maintained. With the aid of a Bausch & Lomb ste reomicroscope the dura was excised and reflected later ally, and the preparation was allowed to equilibrate for -30 min. Bipolar diathermy was used to prevent bleeding from the dural vessels.
Arterial blood samples were taken at regular intervals, and the animals were kept normocapnic by adjusting the stroke volume. Metabolic acidosis was controlled by the administration of sodium bicarbonate (8.4% solution). Core temperature was measured by rectal thermometer and the temperature was maintained at 37"C by a heating blanket. At the outset of the study, the mean arterial blood pressure was 86 ± 5 mm Hg, arterial pH was 7.42 ± 0.05, arterial Pe02 was 31 ± 4 mm Hg, and arterial P02 was 201 ± 25 mm Hg; these parameters were maintained within these ranges for the duration of the experiment.
Measurement of pial arteriolar calibre
Pial arteriolar calibre was measured by the method of Baez (1966) using an image splitter linked through a closed-circuit video display system. A detailed descrip tion of the measurement techniques has appeared previ ously (Robinson and McCulloch, 1990) . Briefly, the indi vidual pial vessels are viewed through a stereomicro scope, and the arteriolar diameter is measured from the degree of shear applied to the image splitter to tangen tially appose the two images. The system is calibrated at x40 and x70 against threads of known diameter, which allows the direct measurement of vascular diameter in absolute units (micrometers).
Sharp glass micropipettes (tip diameter, 10-12 /-lm) were vacuum-filled with either artificial CSF or drugs dis solved in CSF. The composition of the CSF was as fol lows: Na +, 156 mM; K + , 3 mM; Ca 2 + , 2.5 mM; HC03 -, 12 mM; Cl-, 152 mM. The pH was adjusted to 7.2 by aeration with 95% O2 and 5% CO2, Bosentan (30 /-lM), PD155080 (30 /-lM), or endothelin (10 nM) was dissolved in CSF and applied by perivascular microapplication us ing a micromanipulator to position the pipettes in the peri vascular space surrounding the vessel. Small volumes (-5 /-ll) were delivered by a pressure ejection system. In the first study, the ability of Bosentan or PD 155080 to reverse the constriction induced by the perivascular microapplication of ET -I was investigated in three cats with no exposure of the middle cerebral artery (MCA). The calibre of the vessels was recorded for 5-15 min fol lowing the perivascular microapplication of ET-l (10 nM). Bosentan (3() /-lM), PD155080 (30 /-lM), or CSF (pH 7.2) were applied to the ET-l-constricted vessels 5-15 min subsequent to the first microapplication of ET -1. The vessel diameter was measured before insertion of mi-cropipettes and before and after injection of substances; the vessel diameter was monitored for 1-2 min.
The MCA was exposed in seven cats by a neurosur geon via a transorbital approach as previously described (Chen et al. , 1991) . Briefly, the contents of the left orbit were exenterated, and the optic foramen was enlarged to expose the dura and the MCA underlying it. The dura was excised, the MCA and its branches were occluded using bipolar diathermy, and the artery was sectioned. In each cat, the diameter of three to eight pial arterioles was mon itored for 10-20 min prior to MeA occlusion and for 30 min after MCA occlusion. Perivascular microinjections of Bosentan (30 fLM), PDl55080 (30 fLM), and CSF (pH 7. 2) were made 30-210 min following MCA occlusion.
Statistical analysis
The ability of Bosentan or PD155080 to reverse exog enous ET-l-induced vasoconstriction was assessed by unpaired Student t test. The data from the vessels over lying the para sagittal gyrus and from the postocclusion dilated and constricted vessels overlying the suprasylvian and ectosylvian gyri were analyzed using one-way anal ysis of variance (ANOV A) and the Student t test with Bonferroni correction for mUltiple group comparisons (Bosentan or PD155080 vs. CSF). All results are ex pressed as mean ± SD of the percentage of change of pial arteriolar calibre from preinjection baseline (n = the number of arterioles examined).
RESULTS
Reversal of vasoconstriction induced by exogenous endothelin-l
The perivascular microapplication of Bosentan Time (mins) 1995b). Pial arterioles were constricted by the peri vascular microapplication of ET -1 (10 oM); constric tion was -29.1 ± 1. 9% from preinjection baseline (n = 24). CSF applied 5-15 min following microap plication of ET-l had minimal effect on the calibre of vessels constricted by ET -1 (-0.6 ± 4.1% from ET-l-constricted baseline; n = 12). Bosentan (30 fLM) applied 5-15 min after the first microapplica tion of ET -1 caused a marked increase in vessel calibre from the ET-l-constricted baseline (22.4 ± 9.6% from ET-l-constricted baseline; n = 7; p < 0.01; Fig. 1 ). The perivascular administration of PD155080 (30 fLM) to a pial arteriole constricted with ET -1 re sulted in a significant increase in calibre from the level immediately prior to PD155080 injection (mean change in calibre, 21 ± 6.9% from ET-l constricted baseline; n = 8; p < 0.01; Fig. 1 ). The reversal or dilatation was transient with a typical duration of � 30-60 s before the vessel returned to the calibre it had prior to the application of the an tagonist.
Alterations in vascular diameter after
MCA occlusion
The cranial window exposed cortical pial arteri oles overlying the ectosylvian, suprasylvian, and parasagittal gyri. The permanent occlusion of the MCA produced an immediate increase (�50% from preocclusion levels) in pial arteriolar calibre irre spective of the neuroanatomical site of the vessels. vessels on the parasagittal gyrus (anterior cerebral artery territory) displayed sustained dilatations. Pial arterioles located on the suprasylvian and ec tosylvian gyri (the region supplied by the MCA and representing ischaemic penumbra) displayed a mix ture of vasoconstriction and vasodilatation by 30 min after MCA occlusion. In four cats, pial arteri oles on the ectosylvian and suprasylvian gyri dis played sustained vasodilatation. In two cats, there were widespread zones of sustained vasoconstric tion (with reductions in arteriolar calibre >50% from preocclusion levels) within the ectosylvian and suprasylvian gyri. In one cat, there was a cir cumscribed zone of vasoconstriction confined to the ectosylvian gyrus, which was labile over time; elsewhere in the ectosylvian and suprasylvian gyri there was marked vasodilatation. The onset of va soconstriction after MCA occlusion varied consid erably among the vessels. In a few, it was well developed by 10 min after MCA occlusion; in others it began to develop 20 min after MCA occlusion. Once vasoconstriction had developed, it was gen erally sustained. Of the 25 vessels whose calibre was followed sequentially for 30 min postocclusion, 15 displayed marked sustained dilatation and 10 dis played marked sustained vasoconstriction. The fre quency of constriction or dilatation reflects anatom ical bias in the selection of vessels for sequential assessment in the preocclusion and immediate pos tocclusion period. Time (mins Post MCA occlusion)
Vasomotor effect of CSF after MCA occlusion
In vessels overlying the ectosylvian and supra sylvian gyri, the perivascular microapplication of CSF resulted in small reductions in pial arteriolar diameter in the period 30-210 min after occlusion. The magnitude of the vascular responses to perivas cular microapplication of CSF was similar in ves sels that displayed sustained vasodilatation after MCA occlusion and in vessels that displayed sus tained vasoconstriction (Figs. 2 and 3) . The re sponse of pial arterioles to perivascular microappli cation of CSF did not alter significantly in the pe riod 30-210 min after MCA occlusion (Fig. 4) .
Vasomotor effect of Bosentan after MCA occlusion
In vessels overlying the ectosylvian and supra sylvian gyri, the perivascular microapplication of Bosentan (30 !-lM) resulted in marked increases in pial arteriolar diameter in the period 30-210 min after MCA occlusion in all vessels studied, irrespec tive of the nature of their response following MCA occlusion. The diameter of pial arterioles displaying sustained dilatation after MCA occlusion increased from 175 ± 67 to 202 ± 80 !-lm (n = 38) following perivascular microapplication of Bosentan (Figs.  2 and 4) . The response to microapplication of Bosentan on postocclusion dilated arterioles was significantly time-dependent; the response was sig nificantly greater later after MCA occlusion (two way ANOV A, p < 0. 05). The diameter of pial arterioles displaying sustained constnchon after MCA occlusion increased from 97 ± 52 to 153 ± 75 f.Lm (n = 13) following perivascular application of Bosentan (Figs. 3, and 5 ). In vessels overlying the parasagittal gyrus, there was no significant difference between the response of pial arterioles to perivascular microapplication of Bosentan (-2.1 ± 5.5% from preinjection baseline; n = 7) and the response to CSF (-7.1 ± 6.7% from preinjection baseline; n = 5); these investigations were made at 13 1 ± 9 and 114 ± 13 min after MCA occlusion, respectively. The perivascular microapplication of PD 155080 in standard CSF resulted in increases in arteriolar calibre of postocclusion dilated and constricted ar terioles (Figs. 2-5 ). The diameter of pial arterioles displaying sustained dilatation after MCA occlusion increased from 16 1 ± 57 to 173 ± 59 f.Lm (n = 36) following perivascular microapplication of PDI55080 (30 f.LM). The diameter of pial arterioles displaying sustained constriction after MCA occlu sion increased from 92 ± 44 to 150 ± 62 f.Lm (n = 8) following perivascular application of PD 155080.
• .. • . \ . . . . The magnitude of the increase in calibre after mi croapplication of PD155080 was numerically greater in vessels displaying postischaemic constriction than in vessels displaying postischaemic dilatation (Figs. 2 and 3) . The response to microapplication of PD155080 on postocclusion dilated arterioles be came significantly greater as the postocclusion time period increased (two-way ANOVA, p < 0.05; Fig.4) .
In vessels overlying the parasagittal gyrus, there was no significant difference between the response of pial arterioles to perivascular microapplication of PD155080 ( -1.5 ± 6. 9% from preinjection baseline; n = 5) and the response to CSF ( -7.1 ± 6. 7% from preinjection baseline; n = 5); these investigations were made at 141 ± 41 and 114 ± 13 min after MCA occlusion, respectively.
DISCUSSION
The potent vasoconstriction effects of the endo thelins has attracted much attention for their in volvement in almost every vascular pathology, al though the precise definition of their pathophysio logic role has proven elusive (Brunner et aI., 1992; Ziv et aI., 1992; Gellai et aI., 1994; Rubanyi and Polokoff, 1994) . The perivascular microapplication of Bosentan or PD155080 on nonischaemic feline pial arterioles had minimal effect on arteriolar cali bre (Patel et aI., 1994 (Patel et aI., , 1995b ; these results indicate that under normal physiologic conditions there is minimal endothelin-mediated vascular tone. The J Cereb Blood Flow Me/ab, Vol. 16, No. 4, 1996 present data suggest that following focal cerebral ischaemia, endogenous endothelins constrict and restrict the dilatation of cortical arterioles in the ischaemic penumbra. The constrictor effects of en dogenous endothelins (defined by reversal with the endothelin antagonists Bosentan and PD155080) are demonstrable early in the evolution of ischaemic injury, at times when neuroprotective drugs, such as NMDA receptor antagonists, can still salvage tis sue from irreversible damage (Ozyurt et aI., 1988) . Our findings provide insight into a possible patho physiologic role for endothelins in cerebral isch aemia and also provide a basis for the use of endo thelin antagonists in the treatment of occlusive stroke.
A marked reduction in cerebrovascular resis tance and the dilatation of the cerebral vasculature occur at the onset of cerebral ischaemia to try to maintain tissue oxygenation. The mechanism for these events has long been attributed to the release of "chemical products of cerebral metabolism," with hydrogen ions, potassium ions, and adenosine among the most favoured candidates. On the other hand, there is evidence that endogenous constrictor mechanisms evolve that effectively limit tissue per fusion to ischaemic and periischaemic brain regions (Teasdale et aI., 1981) . In focal ischaemia, vasodi lator agents (calcium entry blockers, papaverine, etc.) have been utilised to produce further de creases in vascular resistance, to increase the cali bre of arterioles, and, if systemic hypotension is avoided, to increase tissue blood flow to the isch aemic penumbra (Brandt et aI., 1983; Date and Hossman, 1984; Mohammed et aI., 1985) .
Several mechanisms have been proposed (and disputed) to restrict tissue perfusion in cerebral ischaemia, including intraluminal obstruction, me chanical compression of the intraparenchymal ves sels (consequent to astrocytic swelling and ulti mately tissue oedema), and active vasoconstriction (Teasdale et aI., 1981; Hatashita and Hoff, 1986; Wahl and Schilling, 1993) . The demonstration that arteriolar calibre in the ischaemic penumbra is in creased after microapplication of the endothelin re ceptor antagonists Bosentan and PD155080 indi cates that endogenous endothelins may be involved in limiting blood flow to this zone. While our find ings clearly demonstrate that there is an endothelin mediated component to alterations in vessel calibre following a focal ischaemic insult, endothelin antag onists (including Bosentan) have been shown to markedly reverse the vasospasm of arteries associ ated with subarachnoid hemorrhage in several spe cies (Rubanyi and Pol ok off, 1994) with subarach noid hemorrhage. The stimulus for the increased levels of endothelins is likely to be blood products and agents present at the site of irijury (Yanagisawa et aI., 1988; Kurihara et aI., 1989; Ohlstein and Storer, 1992) .
The trigger for and sources of the putative in creased perivascular endothelins in focal ischaemia are presently unclear. Intracellular concentrations of ET -1, as determined by radioimmunoassay, are increased 24 h after a focal (MCA occlusion) or global (two-vessel occlusion plus hypotension) isch aemic insult (Duverger et aI., 1992; Barone et aI., 1994) . Endothelial cells and neurones from the brain and spinal cord express ET mRN A and ET immu noreactivity, implicating these cells as potential sources of endothelins following an ischaemic result (Giaid et aI., 1989; Lee et aI., 1990; MacCumber et aI., 1990) . Although secretory granules are not gen erally found in endothelial cells, in contrast to neu rones, it is known that endothelial cells do contain some ET-like peptide, which may be released under certain conditions (MacArthur et aI., 1994) . This fact supports evidence that de novo synthesis of this peptide (which may take hours) is not always necessary and may explain the ability of Bosentan and PD155080 to alter or reverse ischaemically in duced perturbations in pial vessel calibre relatively acutely after the insult in the present study.
In a gerbil global ischaemia model, protection of the CAl neurones was achieved by intervention with the endothelin antagonists BQ-123 and SB209670 (Feuerstein et aI., 1994; Ohlstein et aI., 1994) . Increased perfusion of the area following ad ministration of the ET antagonist cannot be ruled out as a mechanism of this therapeutic effect in global ischaemia; however, there is controversial evidence that endothelins may have a direct action on neuronal viability (Hokfelt et aI., 1989; Lustig et aI., 1992; Tence et aI., 1992) .
Hypoxia, following an occlusive insult, it is the most likely stimulus which likely elicits an increase in endothelins to vasoactive concentrations. Sev eral studies in cell culture support this idea (Elton et aI., 1992) . However, evidence in the present study indicates that rheologic factors (or reactive alter ations in vessel calibre) per se are insufficient to elicit vasoactive amounts of endothelins, since there was no vasomotor response to Bosentan or PD155080 in the postocclusion dilated vessels over lying the parasagittal gyrus (with blood flow derived from the anterior cerebral artery). Evidence from cell culture studies indicates that shear stress may induce an increase in ET-l mRNA or ET-l release (Kuchan and Frangos, 1993; Morita et aI., 1993; MacArthur et aI., 1994) . Differences in the source and target of endothelin may occur, depending on the brain injury (Kurihara et al., 1989; Barone et al., 1994) .
Interpretation of our results depends on the se lectivity of action of Bosentan and PD155080 on endothelin receptors. Bosentan inhibits the binding of radiolabelled ET -1 to ETA and ET B receptors with ki values of 5 and 95 nM, respectively (Clozel et aI., 1994) . Bosentan has no demonstrable effects on the binding of other peptides with the exception of neurokinin A, the binding of which was reduced at very high Bosentan concentrations (10 fJ-M) (Clo zel et aI., 1994) . In contrast, PD155080 inhibits binding of radiolabelled ET -1 to ETA and ET B re ceptors with ICso values of 7.8 nM and 3.5 fJ-M, respectively (Doherty et aI., 1995) . In feline pial arterioles in situ, perivascular microapplication of Bosentan or PD155080 have no effect on arteriolar calibre under normoxic, normocapnic, and nor motensive conditions (Patel et aI. , 1994 (Patel et aI. , , 1995b . Coadministration of Bosentan or PD155080 with ET -I (10 nM) inhibits the ET -I-induced constric tion of pial arterioles (but not that produced by other vasoconstrictors) with an ICso of I fJ-M for both antagonists; complete blockade was achieved with coapplication of higher concentrations of the antagonists (micropipette concentration, 30 fJ-M) (Patel et aI., 1994 (Patel et aI., , 1995b . Despite the slow disso ciation of endothelins from their receptors (Mar sault et aI., 1993) , the present data in normal cats indicate that partial reversal of ET -I-induced cere bral vasoconstriction can be achieved by delayed treatment with either Bosentan or PD155080.
We have examined the effects of combined ETA-ET B receptor antagonist (Bosentan) and an ETAselective receptor antagonist (PDI55080) on isch aemic arterioles. Bosentan and PD155080 elicited similar magnitude of effects on ischaemic dilated and constricted arterioles. Activation of ETA or ET B can mediate vascular contractions depending on the vessel examined. In feline pial arterioles, however, the ET -I-induced vasoconstriction ap pears to be mediated via ETA receptors, whereas ET B activation produces vasodilatation (Kobari et aI. , 1994; Patel et aI., unpublished observations) . Receptor characterisation of ET-l cerebrovascular actions in other species generally supports such a view of the function of ET receptor subtypes (Ki tazono et aI., 1993; Feger et aI., 1994) . The use of a mixed antagonist such as Bosentan does not allow elucidation of the endothelin receptor subtype that mediates the observed cerebrovascular constric tion. However, the ability of the endothelin ETA receptor-selective antagonist PD155080 to increase the calibre of both postocclusion dilated and con stricted arterioles indicates that ETA receptor acti-vation is probably the dominant mediator of the ce rebrovascular effects of endogenous ET -1 following focal ischaemia. The ability of an ETA receptor an tagonist to increase CBF to the ischaemic penum bra and reduce ischaemic neuronal damage has been demonstrated (Patel et aI., 1995a ). An impor tant aspect of the pharmacology of Bosentan and PD155080 is the ability to gain access to the vascu lar smooth muscle of cerebral resistance vessels af ter i.v. administration (Patel et aI., 1994 (Patel et aI., , 1995b . These observations and the finding that the calibre of vessels in the ischaemic penumbra can be in creased by Bosentan and PD155080 provide a basis for assessing the therapeutic utility of endothelin receptor antagonists in focal cerebral ischaemia.
